 Maintenance Therapy Week 27 through 36 Weeks 27 to 36 study subjects with complete response CR, partial response PR, or stable disease SD may be offered maintenance therapy with administration of 1 mg IM Poly-ICLC twice weekly. At week 36 a repeat tumor assessment, including optional tumor biopsy, will be performed. 